Neoadjuvant Chemoradiotherapy Versus Chemotherapy for the Treatment of Locally Advanced Esophageal Adenocarcinoma in the European Multicenter ENSURE Study

医学 食管腺癌 放化疗 内科学 食管癌 化疗 腺癌 多中心研究 新辅助治疗 随机对照试验 普通外科 癌症 肿瘤科 乳腺癌
作者
Jessie A. Elliott,Fredrik Klevebro,Styliani Mantziari,Sheraz R. Markar,Lucas Goense,Asif Johar,Pernilla Lagergren,Giovanni Zaninotto,Richard van Hillegersberg,Mark I. van Berge Henegouwen,Markus Schäfer,Magnus Nilsson,George B. Hanna,John V. Reynolds
出处
期刊:Annals of Surgery [Ovid Technologies (Wolters Kluwer)]
卷期号:278 (5): 692-700 被引量:1
标识
DOI:10.1097/sla.0000000000006018
摘要

This study aimed to compare clinicopathologic, oncologic, and health-related quality of life (HRQL) outcomes following neoadjuvant chemoradiation (nCRT) and chemotherapy (nCT) in the ENSURE international multicenter study.nCT and nCRT are the standards of care for locally advanced esophageal cancer (LAEC) treated with curative intent. However, no published randomized controlled trial to date has demonstrated the superiority of either approach.ENSURE is an international multicenter study of consecutive patients undergoing surgery for LAEC (2009-2015) across 20 high-volume centers (NCT03461341). The primary outcome measure was overall survival (OS), secondary outcomes included histopathologic response, recurrence pattern, oncologic outcome, and HRQL in survivorship.A total of 2211 patients were studied (48% nCT, 52% nCRT). pCR was observed in 4.9% and 14.7% ( P <0.001), with R0 in 78.2% and 94.2% ( P <0.001) post nCT and nCRT, respectively. Postoperative morbidity was equivalent, but in-hospital mortality was independently increased [hazard ratio (HR)=2.73, 95% CI: 1.43-5.21, P= 0.002] following nCRT versus nCT. Probability of local recurrence was reduced (odds ratio=0.71, 95% CI: 0.54-0.93, P =0.012), and distant recurrence-free survival time reduced (HR=1.18, 95% CI: 1.02-1.37, P =0.023) after nCRT versus nCT, with no difference in OS among all patients (HR=1.10, 95% CI: 0.98-1.25, P =0.113). On subgroup analysis, patients who underwent R0 resection following nCT as compared with nCRT had improved OS (median: 60.7 months, 95% CI: 49.5-71.8 vs 40.8 months, 95% CI: 42.8-53.4, P <0.001).In this European multicenter study, nCRT compared with nCT was associated with reduced probability of local recurrence but reduced distant recurrence-free survival for patients with LAEC, without differences in OS. These data support tailored patient-specific decision-making in the overall approach to achieving optimum outcomes in LAEC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Kindy发布了新的文献求助10
2秒前
5秒前
zho驳回了CodeCraft应助
7秒前
7秒前
金阿垚在科研完成签到,获得积分10
10秒前
Camellia发布了新的文献求助10
11秒前
完美世界应助童0731采纳,获得10
12秒前
付佳佳完成签到,获得积分10
14秒前
SciGPT应助sunshine采纳,获得10
15秒前
wzh发布了新的文献求助10
15秒前
柯云完成签到,获得积分10
17秒前
彭于晏应助忧郁画板采纳,获得10
17秒前
琼琼发布了新的文献求助10
21秒前
23秒前
23秒前
充电宝应助ss采纳,获得10
25秒前
26秒前
cynthiaLLL完成签到 ,获得积分10
26秒前
share完成签到,获得积分10
26秒前
深情安青应助受伤绿柏采纳,获得10
27秒前
wallonce发布了新的文献求助10
28秒前
29秒前
liu完成签到 ,获得积分10
30秒前
h3m完成签到 ,获得积分10
31秒前
ning完成签到 ,获得积分10
31秒前
爆米花应助学不懂采纳,获得10
32秒前
m李完成签到 ,获得积分10
34秒前
35秒前
35秒前
36秒前
37秒前
zho发布了新的文献求助10
38秒前
一枚研究僧应助w王w采纳,获得10
39秒前
爆米花应助wallonce采纳,获得10
40秒前
40秒前
流星雨发布了新的文献求助10
41秒前
43秒前
43秒前
44秒前
Epiphany~王勇胜完成签到,获得积分10
44秒前
高分求助中
Smart but Scattered: The Revolutionary Executive Skills Approach to Helping Kids Reach Their Potential (第二版) 1000
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 700
The Heath Anthology of American Literature: Early Nineteenth Century 1800 - 1865 Vol. B 500
A new species of Velataspis (Hemiptera Coccoidea Diaspididae) from tea in Assam 500
Machine Learning for Polymer Informatics 500
《关于整治突出dupin问题的实施意见》(厅字〔2019〕52号) 500
2024 Medicinal Chemistry Reviews 480
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3222475
求助须知:如何正确求助?哪些是违规求助? 2871125
关于积分的说明 8173855
捐赠科研通 2538042
什么是DOI,文献DOI怎么找? 1370245
科研通“疑难数据库(出版商)”最低求助积分说明 645736
邀请新用户注册赠送积分活动 619535